ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1145.1 | 891.5 | 1150.2 |
| Other income | 17.0 | 9.4 | 9.9 |
| Total income | 1162.1 | 900.9 | 1160.1 |
| Profit before exceptional items & tax | 262.0 | 169.6 | 281.8 |
| Profit before tax | 262.0 | 169.6 | 281.8 |
| Net profit | 195.8 | 126.3 | 209.9 |
| Operating margin | 22.5% | 18.8% | 24.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -6.70% |
|---|---|
| Net profit, quarter on quarter | +55.00% |
| Revenue, year on year | -0.40% |
| Operating profit, year on year | -9.90% |
| Operating profit, quarter on quarter | +52.90% |
BSE results filing, NSE: PGHH. Figures extracted from the filing.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹7,232.00
- Market cap
- ₹23,476 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 29.7×Sector 41.3×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Results Update
PGHH reported Q2 FY26 sales of ₹1145 crores flat and PAT of ₹196 crores, down 7% YoY. Commodity and FX headwinds weighed on margins, partly offset by productivity.
Procter & Gamble Hygiene & Healthcare Other Announcement
Procter & Gamble Hygiene and Health Care Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, with the exchange.
Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.